Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | VRT | Class A Common Stock | Gift | $0 | -2M | -100% | $0.00* | 0 | Jul 30, 2024 | See Footnote | F1 |
holding | VRT | Class A Common Stock | 62.3K | Jul 30, 2024 | See Footnote | F2 | |||||
holding | VRT | Class A Common Stock | 200 | Jul 30, 2024 | See Footnote | F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | VRT | Stock Option | 116K | Jul 30, 2024 | Class A Common Stock | 116K | $12.05 | Direct | F4, F5 | |||||
holding | VRT | Stock Option | 116K | Jul 30, 2024 | Class A Common Stock | 116K | $20.56 | Direct | F4, F5 | |||||
holding | VRT | Stock Option | 116K | Jul 30, 2024 | Class A Common Stock | 116K | $11.50 | Direct | F4, F5 | |||||
holding | VRT | Stock Option | 100K | Jul 30, 2024 | Class A Common Stock | 100K | $15.84 | Direct | F4, F5 | |||||
holding | VRT | Stock Option | 50K | Jul 30, 2024 | Class A Common Stock | 50K | $72.09 | Direct | F4, F5 |
Id | Content |
---|---|
F1 | The Reporting Person previously indirectly beneficially owned these shares of Class A common stock through Atlanta Sons LLC. As of July 30, 2024, the Reporting Person has ceased to serve as manager of Atlanta Sons LLC and therefore has ceased to have beneficial ownership of such securities. As of the date of this Form 4, these securities have not been sold and remain held by Atlanta Sons LLC. |
F2 | Reflects securities held directly by the Reporting Person's spouse. |
F3 | Reflects securities held directly by David M. Cote 2018 Revocable Trust, of which the Reporting Person is the trustee. |
F4 | The Reporting Person holds an aggregate of 497,826 stock options, including (i) 115,942 stock options granted on February 7, 2020, which vested as to 28,985 on February 7, 2021, 28,986 on February 7, 2022, 28,985 on February 7, 2023 and 28,986 on February 7, 2024, (ii) 115,942 stock options granted on February 4, 2021, which vested as to 28,986 on each of February 4, 2022 and February 4, 2023 and 28,985 on February 4, 2024, and which will vest as to 28,985 on February 4, 2025, (iii) 115,942 stock options granted on March 3, 2022, which vested as to 28,985 on each of March 3, 2023 and March 3, 2024, and which will vest as to 28,986 on each of March 3, 2025 and March 3, 2026, (cont'd in FN5) |
F5 | (cont'd from FN4) (iv) 100,000 stock options granted on March 7, 2023, which vested as to 25,000 on March 15, 2024 and which will vest as to 25,000 on each of March 15, 2025, March 15, 2026, and March 15, 2027, and (v) 50,000 stock options granted to the reporting person on March 7, 2024, which will vest as to 12,500 on each of March 15, 2025, March 15, 2026, March 15, 2027 and March 15, 2028. No exercises, dispositions or other transactions with respect to the stock options are being reported in this Form 4. |